Show simple item record

dc.contributor.authorIlson, DH
dc.contributor.authorTabernero, J
dc.contributor.authorProkharau, A
dc.contributor.authorArkenau, HT
dc.contributor.authorGhidini, M
dc.contributor.authorFujitani, K
dc.contributor.authorVan, CE
dc.contributor.authorThuss-Patience, P
dc.contributor.authorBeretta, GD
dc.contributor.authorMansoor, Was
dc.contributor.authorZhavrid, E
dc.contributor.authorAlsina, M
dc.contributor.authorGeorge, B
dc.contributor.authorCatenacci, D
dc.contributor.authorMcGuigan, S
dc.contributor.authorMakris, L
dc.contributor.authorDoi, T
dc.contributor.authorShitara, K
dc.date.accessioned2019-11-19T16:00:58Z
dc.date.available2019-11-19T16:00:58Z
dc.date.issued2019en
dc.identifier.citationIlson DH, Tabernero J, Prokharau A, Arkenau HT, Ghidini M, Fujitani K, et al. Efficacy and safety of trifluridine/tipiracil treatment in patients with metastatic gastric cancer who had undergone gastrectomy: subgroup analyses of a randomized clinical trial. JAMA Oncol. 2019.en
dc.identifier.pmid31600365en
dc.identifier.doi10.1001/jamaoncol.2019.3531en
dc.identifier.urihttp://hdl.handle.net/10541/622399
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1001/jamaoncol.2019.3531en
dc.titleEfficacy and safety of trifluridine/tipiracil treatment in patients with metastatic gastric cancer who had undergone gastrectomy: subgroup analyses of a randomized clinical trialen
dc.typeArticleen
dc.contributor.departmentDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, New Yorken
dc.identifier.journalJAMA Oncologyen


This item appears in the following Collection(s)

Show simple item record